Lepu Biopharma Co. Ltd. Class H had a revenue of 465.94M in the quarter ending Jun 30, 2025, with 98.69%. This bring the company's revenue in the last twelve months to 700.45M, Decreased 90.38%. In the fiscal year ending Dec 31, 2024, Lepu Biopharma Co. Ltd. Class H had annual revenue of 367.79M with 63.21% growth.